Don B. Sanders

Also affiliated with Riley Hospital for Children, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis

MedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations”.

Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations

Annals of the American Thoracic Society(2023)10.1513/annalsats.202306-576oc

N/A

0.703DataRank · unranked

20 citations

Lindsay J. Caverly, Linda M. Kalikin, Lisa A. Carmody, Scott McClellan, William LeBar +8 more

Nutritional status and lung function in children with pancreatic-sufficient cystic fibrosis

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.12.014

N/A

0.515DataRank · unranked

30 citations

William Okoniewski, Don B. Sanders, Clement L. Ren, Daniel J. Weiner, Erick Forno +1 more

The association between gut microbiome and growth in infants with cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.08.001

N/A

0.481DataRank · unranked

7 citations

Y Chen, Wangfei Wang, Mladen Rasic, Joseph Hatch, Don B. Sanders +6 more

Adjunctive Systemic Corticosteroids for Pulmonary Exacerbations of Cystic Fibrosis

Annals of the American Thoracic Society(2023)10.1513/annalsats.202308-673oc

N/A

0.449DataRank · unranked

19 citations

Sonya L. Heltshe, Katherine Odem‐Davis, Natalie E. West, Don B. Sanders, B. Fogarty +4 more

Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbations

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.03.001

N/A

0.357DataRank · unranked

6 citations

Ryan N. Hansen, Donald L. Patrick, Ashley Tabah, Sonya L. Heltshe, Patrick A. Flume +6 more

Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.04.014

N/A

0.330DataRank · unranked

8 citations

Ashley R. Deschamp, Joseph Hatch, James E. Slaven, Netsanet Gebregziabher, Mariette Kemner-van de Corput +9 more

Impact of lumacaftor/ivacaftor and tezacaftor/ivacaftor on treatment response in pulmonary exacerbations of F508del/F508del cystic fibrosis

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.06.012

N/A

0DataRank · unranked

10 citations

Sonya L. Heltshe, Katherine Odem‐Davis, Natalie E. West, Don B. Sanders, B. Fogarty +4 more

Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment

Annals of the American Thoracic Society(2023)10.1513/annalsats.202301-078oc

N/A

0DataRank · unranked

5 citations

Don B. Sanders, James E. Slaven, Anna Faino, Ranjani Somayaji, Ron Gibson +3 more

Characteristics associated with cystic fibrosis-related pulmonary exacerbation treatment location

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.10.004

N/A

0DataRank · unranked

4 citations

Ryan N. Hansen, Sonya L. Heltshe, Patrick A. Flume, Christopher H. Goss, Natalie E. West +3 more

607 Characteristics of individuals in the United States ineligible for ivacaftor and elexacaftor-tezacaftor-ivacaftor

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01529-1

N/A

0DataRank · unranked

1 citations

N. Hamblett, M. Rosenfeld, Deepika Polineni, E. Dasenbrook, Rhonda D. Szczesniak +2 more

104 Effect of acute systemic corticosteroids on clinical outcomes in cystic fibrosis pulmonary exacerbations

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01039-1

N/A

0DataRank · unranked

0 citations

S. Heltshe, K. Odem-Davis, N.E. West, Don B. Sanders, B. Fogarty +4 more

Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USA

European Respiratory Journal(2024)10.1183/13993003.01146-2024

N/A

0DataRank · unranked

16 citations

J. Ostrenga, Don B. Sanders, Wayne J. Morgan, Carlo Castellani, Rhonda D. Szczesniak +2 more

Systematic comparison of methods for offline breath sampling

Analytical and Bioanalytical Chemistry(2025)10.1007/s00216-025-06025-5

N/A

0DataRank · unranked

8 citations

A. B. Christensen, Eray Schulz, Serenidy Eckerle, Michael D. Davis, Don B. Sanders +2 more

Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic Fibrosis

Pediatric Pulmonology(2025)10.1002/ppul.71024

N/A

0DataRank · unranked

2 citations

Maria T. Nelson, Sydney E. Ross, Adrian J. Verster, Drake C. Bouzek, Alex Eng +9 more

An observational study of the lung microbiome and lung function in young children with cystic fibrosis across two countries with differing antibiotic practices

Microbial Pathogenesis(2025)10.1016/j.micpath.2025.107628

N/A

0DataRank · unranked

2 citations

Y.S Chen, Mladen Rasic, Christian Ascoli, Joseph Hatch, Nicole K. Nemsick +9 more

Correlates of FEV₁ deficit in pulmonary exacerbations of cystic fibrosis and associated clinical outcomes

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.12.007

N/A

0DataRank · unranked

0 citations

Sonya L. Heltshe, Don B. Sanders, Natalie E. West, B. Fogarty, Donald R. VanDevanter +3 more

Impact of the COVID-19 Pandemic on Pediatric Cystic Fibrosis Pulmonary Exacerbations

IUScholarWorks (Indiana University)(2020)10.22541/au.160491826.69450223/v1

N/A

0DataRank · unranked

0 citations

Misty Thompson, James E. Slaven, Don B. Sanders, Clement L. Ren, Shreya Patel

Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.12.003

N/A

0DataRank · unranked

0 citations

Jonathan D. Cogen, Donald R. VanDevanter, John J. LiPuma, Natalie E. West, Don B. Sanders +6 more

Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic

Pediatric Pulmonology(2021)10.1002/ppul.25250

N/A

0DataRank · unranked

41 citations

Misty Thompson, James E. Slaven, Don B. Sanders, Clement L. Ren, Shreya Patel

Association of site of treatment with clinical outcomes following intravenous antimicrobial treatment of a pulmonary exacerbation

Journal of Cystic Fibrosis(2021)10.1016/j.jcf.2021.11.009

N/A

0DataRank · unranked

19 citations

Umer Khan, Sonya L. Heltshe, M. Skalland, Natalie E. West, Donald R. VanDevanter +3 more

Antipseudomonal treatment decisions during CF exacerbation management

Journal of Cystic Fibrosis(2022)10.1016/j.jcf.2022.04.006

N/A

0DataRank · unranked

12 citations

Natalie E. West, Don B. Sanders, M. Skalland, Christopher H. Goss, Patrick A. Flume +2 more

Immunoreactive Trypsinogen in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor–Tezacaftor–Ivacaftor

International Journal of Neonatal Screening(2023)10.3390/ijns9010010

N/A

0DataRank · unranked

19 citations

Jana Yeley, Cynthia D. Brown, Melissa Wesson, Barbara G. Lesko, James E. Slaven +4 more

Re-examining baseline lung function recovery following IV-treated pulmonary exacerbations

Journal of Cystic Fibrosis(2023)10.1016/j.jcf.2023.02.006

N/A

0DataRank · unranked

11 citations

Renee Russell, Donald R. VanDevanter, Don B. Sanders, Sonya L. Heltshe